Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$387.35 - $450.26 $3.01 Million - $3.5 Million
-7,776 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$246.9 - $321.87 $35,306 - $46,027
-143 Reduced 1.81%
7,776 $2.47 Million
Q3 2020

Nov 12, 2020

SELL
$232.22 - $282.96 $2,554 - $3,112
-11 Reduced 0.14%
7,919 $1.96 Million
Q2 2020

Aug 11, 2020

BUY
$185.43 - $279.56 $59,708 - $90,018
322 Added 4.23%
7,930 $2.09 Million
Q1 2020

May 08, 2020

SELL
$161.17 - $221.51 $6,930 - $9,524
-43 Reduced 0.56%
7,608 $1.44 Million
Q4 2019

Feb 18, 2020

BUY
$189.68 - $222.09 $1.45 Million - $1.7 Million
7,651 New
7,651 $1.68 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Bullseye Asset Management LLC Portfolio

Follow Bullseye Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bullseye Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bullseye Asset Management LLC with notifications on news.